Matsuda Y et al. reported increased FGFR2 IIIc expression among colorectal carcinomas samples and a human anti-FGFR2 IIIc monoclonal antibody was reported to inhibit growth in colorectal carcinoma cells91. Here, FGFR2 is linked to colorectal carcinoma.